Abbott Laboratories

NYSE: ABT
$116.89
+$0.06 (+0.1%)
Real Time Data Delayed 15 Min.

ABT Chart and Intraday Price

ABT Company Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 100 ABBOTT PARK ROAD, ABBOTT PARK, IL, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 205,827.06M USD
Shares Outstanding 1,735,180,000
Abbott Laboratories is a global healthcare company with a broad portfolio of products across various segments, including pharmaceuticals, diagnostics, nutritional products, and medical devices. Founded in 1888 and headquartered in North Chicago, Illinois, Abbott is known for its innovative solutions in managing health conditions such as diabetes, cardiovascular diseases, and chronic pain. It also offers a range of diagnostics equipment and tests for infectious diseases, including HIV and influenza, as well as nutritional products for both pediatric and adult patients. Abbott's commitment to improving lives is evident through its diverse offerings aimed at enhancing health and well-being worldwide.

ABT Articles

A recession is looming. Despite the S&P 500 nearing its all-time high, the yield curve inverted and the Sahm Rule was activated. The Federal Reserve is also poised to initiate the first interest...
Investors have been on a roller coaster ride for the past four years and the stock market may be heading into another big loop higher.  Federal Reserve chairman Jay Powell gave his strongest...
24/7 Wall St. Insights Stocks that consistently raise their dividends offer investors huge total return potential. Dividend stocks will become more popular as interest rates decline. Grab this free...
24/7 Insights AI stocks are facing headwinds and sky high valuations are cooling down J.P. Morgan’s top picks are in May are stable, established brands 2 legendary, high-yield dividend stocks Wall...
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
These eight top Dividend Aristocrats pay among the biggest dividends in the sectors that typically do well during a recession. With even moderate appreciation in their share prices, investors should...
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson,...
Before U.S. markets open on Wednesday, these four companies are set to report quarterly earnings.
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Carnival, Deere, Delta Air Lines, DexCom, Enovix, First Republic Bank, GitLab, Hartford Financial Services, Interpublic...
U.S. equities are trading somewhat higher in Tuesday's premarket session as investors wait to hear what Federal Reserve chief Jerome Powell has to say to Congress.
With the potential for big downside still looming, and interest rates definitely headed higher, stock investors may want to consider these seven Dividend Aristocrats that posted solid third-quarter...
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Biohaven, Edwards Lifesciences, Enphase Energy, Halliburton, Invesco, Liberty Energy, Mattel, Netflix, Permian Resources,...
Here is a look at what to expect from these four companies when they report quarterly results before markets open on Wednesday.
With the potential for a serious downside move looming, and interest rates definitely headed higher, investors may want to consider the Dividend Aristocrats. These seven are in defensive sectors and...